2020
DOI: 10.21037/aol-20-21
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness and safety of pembrolizumab as bridging to hematopoietic stem cell transplantation in relapsed and refractory classical Hodgkin’s lymphoma: a retrospective observational study

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles